A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Clinical trial NCT00050427 · COMPLETED

Trial details

NCT number: NCT00050427
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Neoplasms Neoplasms by Site Breast Diseases Skin Diseases

Start date: 2002-12-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.